Published in Postgrad Med J on October 01, 2004
Early identification of refractory epilepsy. N Engl J Med (2000) 12.43
Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group. Lancet (1995) 4.98
An active-control trial of lamotrigine monotherapy for partial seizures. Neurology (1998) 2.24
An overview of the preclinical aspects of topiramate: pharmacology, pharmacokinetics, and mechanism of action. Epilepsia (2000) 2.08
Topiramate: as monotherapy in newly diagnosed epilepsy. CNS Drugs (2003) 2.06
Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand (2003) 1.90
Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology (2001) 1.81
Epilepsy syndrome, focus location, and treatment choice affect testicular function in men with epilepsy. Neurology (2004) 1.74
The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia (1997) 1.72
Topiramate monotherapy for partial onset seizures. Epilepsia (1997) 1.58
Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology (2000) 1.56
Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers. Epilepsia (2002) 1.54
New drug treatments for epilepsy. J Neurol Neurosurg Psychiatry (2001) 1.50
Lamotrigine substitution study: evidence for synergism with sodium valproate? 105 Study Group. Epilepsy Res (1997) 1.49
Clinical recommendations for oxcarbazepine. Seizure (2001) 1.45
Psychiatric adverse events during levetiracetam therapy. Neurology (2003) 1.38
A randomized, placebo-controlled study of topiramate in primary generalized tonic-clonic seizures. Topiramate YTC Study Group. Neurology (1999) 1.29
The mechanisms of action of commonly used antiepileptic drugs. Pharmacol Ther (2001) 1.28
Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia (1999) 1.23
Oral contraceptives reduce lamotrigine plasma levels. Neurology (2003) 1.18
Visual field defects with vigabatrin: epidemiology and therapeutic implications. CNS Drugs (2001) 1.18
Discontinuation of levetiracetam because of behavioral side effects: a case-control study. Neurology (2003) 1.17
A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials. Epilepsy Behav (2003) 1.15
Newer antiepileptic drugs and cognitive issues. Epilepsia (2003) 1.14
Levetiracetam psychosis in children with epilepsy. Epilepsia (2001) 1.14
Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia (1999) 1.11
Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia (2002) 1.11
A randomised open multicentre comparative trial of lamotrigine and carbamazepine as monotherapy in patients with newly diagnosed or recurrent epilepsy. Epilepsy Res (1996) 1.10
Interactions between antiepileptic drugs and hormonal contraception. CNS Drugs (2002) 1.09
Topiramate and psychiatric adverse events in patients with epilepsy. Epilepsia (2003) 1.09
The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia (2003) 1.09
Safety review of adult clinical trial experience with lamotrigine. Drug Saf (1998) 1.08
Angle-closure glaucoma associated with ciliary body detachment in patients using topiramate. Arch Ophthalmol (2003) 1.07
Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations. Seizure (2003) 1.06
Higher androgens and weight gain with valproate compared with lamotrigine for epilepsy. Epilepsy Res (2003) 1.00
Seizure-inducing effects of antiepileptic drugs: a review. Acta Neurol Scand (1996) 0.97
Lamotrigine: a review of its use in bipolar disorder. Drugs (2003) 0.97
Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy. Neurology (2003) 0.96
Epilepsy and pregnancy: Report of an Epilepsy Research Foundation Workshop. Epilepsy Res (2003) 0.96
Safety and tolerability of oxcarbazepine in elderly patients with epilepsy. Epilepsy Behav (2003) 0.95
Hormone profiles in young adults with epilepsy treated with sodium valproate or lamotrigine monotherapy. Epilepsia (2001) 0.94
Review of lamotrigine and its clinical applications in epilepsy. Expert Opin Pharmacother (2003) 0.90
Topiramate monotherapy for childhood absence seizures: an open label pilot study. Seizure (2002) 0.90
Adding topiramate to valproate therapy may cause reversible hepatic failure. Epileptic Disord (2003) 0.90
A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology (2003) 0.89
Conversion to monotherapy: clinical trials in patients with refractory partial seizures. Neurology (2003) 0.89
Polytherapy in epilepsy: the experimental evidence. Epilepsy Res (2002) 0.89
Seizure freedom with more than one antiepileptic drug. Seizure (2002) 0.88
Effects of oxcarbazepine on sodium concentration and water handling. Ann Neurol (2002) 0.88
A paradoxical effect of levetiracetam may be seen in both children and adults with refractory epilepsy. Seizure (2003) 0.88
A comparison of monotherapy with lamotrigine or carbamazepine in patients with newly diagnosed partial epilepsy. Epilepsy Res (2001) 0.88
A Systematic Review of the Effects of Lamotrigine on Cognitive Function and Quality of Life. Epilepsy Behav (2001) 0.86
Peripheral retinal dysfunction in patients taking vigabatrin. Neurology (2003) 0.85
The clinical impact of new antiepileptic drugs after a decade of use in epilepsy. Epilepsy Res (2002) 0.85
Long-term experience with topiramate as adjunctive therapy and as monotherapy in patients with partial onset seizures: retrospective survey of open-label treatment. Epilepsia (1997) 0.84
The impact of epilepsy on subjective health status. Curr Neurol Neurosci Rep (2003) 0.84
Oxcarbazepine: a review of its use in children with epilepsy. Paediatr Drugs (2003) 0.84
Serum sex hormone levels after replacing carbamazepine with oxcarbazepine. Eur J Clin Pharmacol (1995) 0.83
Effect of antiepileptic drugs on cognitive function in individuals with epilepsy: a comparative review of newer versus older agents. Drugs (2002) 0.83
Medical treatment of epilepsy. Expert Opin Emerg Drugs (2003) 0.83
Newer anticonvulsants: dosing strategies and cognition in treating patients with mood disorders and epilepsy. J Clin Psychiatry (2003) 0.83
Oxcarbazepine for Treatment of Partial Epilepsy: A Review and Recommendations for Clinical Use. Epilepsy Behav (2000) 0.82
An open-label study of levetiracetam at individualised doses between 1000 and 3000 mg day(-1) in adult patients with refractory epilepsy. Seizure (2003) 0.81
[Ad hoc change from carbamazepine to oxcarbazepine--effectiveness and tolerance. A retrospective analysis]. Nervenarzt (2001) 0.81
Levetiracetam: treatment in epilepsy. Expert Opin Pharmacother (2003) 0.80
Lamotrigine Monotherapy Improves Depressive Symptoms in Epilepsy: A Double-Blind Comparison with Valproate. Epilepsy Behav (2001) 0.79
Exacerbation of juvenile myoclonic epilepsy with lamotrigine. Neurology (2001) 0.78
Complex partial seizures: EEG foci and response to carbamazepine and sodium valproate. J Neurol Neurosurg Psychiatry (1985) 0.78
Use of topiramate in childhood generalized seizure disorders. J Child Neurol (2000) 0.78
An assessment of zonisamide as an anti-epileptic drug. Expert Opin Pharmacother (2000) 0.78
Levetiracetam monotherapy for primary generalised epilepsy. Seizure (2003) 0.78
Efficacy and tolerability of levetiracetam during 1-year follow-up in patients with refractory epilepsy. Seizure (2003) 0.77
Effects of topiramate in two models of genetically determined generalized epilepsy, the GAERS and the Audiogenic Wistar AS. Epilepsia (2003) 0.77
High dose gabapentin in refractory partial epilepsy: clinical observations in 50 patients. Epilepsy Res (1998) 0.76
Review of new antiepileptic drugs as initial therapy. Epilepsia (2003) 0.76
Non convulsive status epilepticus after replacement of valproate with lamotrigine. J Neurol (2002) 0.76
Preliminary efficacy of levetiracetam in monotherapy. Epileptic Disord (2003) 0.76
[Anticonvulsant combination therapy: rational concepts versus real effectiveness]. Fortschr Neurol Psychiatr (1998) 0.76
Chronic management of seizures in the syndromes of idiopathic generalized epilepsy. Epilepsia (2003) 0.75
Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56
Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med (1994) 6.05
Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an International Academy on Nutrition and Aging (IANA) Task Force. J Nutr Health Aging (2009) 5.98
Interpreting DNA fingerprint clusters of Mycobacterium tuberculosis. European Concerted Action on Molecular Epidemiology and Control of Tuberculosis. Int J Tuberc Lung Dis (1999) 2.66
Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29
Risk of Mycobacterium tuberculosis transmission in a low-incidence country due to immigration from high-incidence areas. J Clin Microbiol (2001) 2.24
Standard magnetic resonance imaging is inadequate for patients with refractory focal epilepsy. J Neurol Neurosurg Psychiatry (2002) 2.20
Myopic children show insufficient accommodative response to blur. Invest Ophthalmol Vis Sci (1993) 2.08
Recombinant human B cell stimulatory factor 2 (BSF-2/IFN-beta 2) regulates beta-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett (1987) 2.04
T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis. Glia (2001) 1.91
B lymphocytes producing demyelinating autoantibodies: development and function in gene-targeted transgenic mice. J Exp Med (1998) 1.85
IS1245 restriction fragment length polymorphism typing of Mycobacterium avium isolates: proposal for standardization. J Clin Microbiol (1998) 1.80
Effects of cytokines on the liver. Hepatology (1991) 1.76
Predictors of MCAT scores for black Americans. J Natl Med Assoc (1987) 1.68
Transverse-momentum and pseudorapidity distributions of charged hadrons in pp collisions at square root of s = 7 TeV. Phys Rev Lett (2010) 1.67
The dermatoscopic pattern of clear-cell acanthoma resembles psoriasis vulgaris. Dermatology (2001) 1.66
On the association between valproate and polycystic ovary syndrome. Epilepsia (2001) 1.65
Cleavage of zearalenone-glycoside, a "masked" mycotoxin, during digestion in swine. Zentralbl Veterinarmed B (1990) 1.64
Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy. Am J Pathol (1998) 1.62
Erythrocyte K-Cl cotransport: properties and regulation. Am J Physiol (1992) 1.56
The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. J Immunol (1997) 1.52
Intrasubject reproducibility of presurgical language lateralization and mapping using fMRI. Neurology (2003) 1.50
Multidimensional assessment of personality in patients with psychogenic non-epileptic seizures. J Neurol Neurosurg Psychiatry (2004) 1.48
TNFR1 signalling is critical for the development of demyelination and the limitation of T-cell responses during immune-mediated CNS disease. Brain (2000) 1.47
Diagnostic delay in psychogenic nonepileptic seizures. Neurology (2002) 1.45
Asymmetric repair of bacteriophage T7 heteroduplex DNA. Mol Gen Genet (1981) 1.44
Targeting of an abundant cytosolic form of the protein import receptor at Toc159 to the outer chloroplast membrane. J Cell Biol (2001) 1.44
Hot topic: Bovine milk samples yielding negative or nonspecific results in bacterial culturing--the possible role of PCR-single strand conformation polymorphism in mastitis diagnosis. J Dairy Sci (2012) 1.42
[Chronic fatigue syndrome. Definition, diagnostic measures and therapeutic possibilities]. Nervenarzt (1996) 1.42
Effects of intralipid infusion on blood viscosity and other haemorheological parameters in neonates and children. Acta Paediatr (2004) 1.41
Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur Arch Psychiatry Clin Neurosci (1997) 1.41
The greater acceptance and utilization of nurse practitioners. Am J Manag Care (2001) 1.39
Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: a gender-related study. Epilepsia (1999) 1.39
Changes in enteric neurone phenotype and intestinal functions in a transgenic mouse model of enteric glia disruption. Gut (2005) 1.39
[Correlation between chronic hyperplastic laryngitis and infection with human papillomaviruses]. HNO (1993) 1.38
High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxel. Ann Oncol (2001) 1.38
Perforated appendicitis within an inguinal hernia: case report and review of the literature. Am J Gastroenterol (1997) 1.37
Nationwide linkage analysis in Scotland to assess mortality following hospital admission for Crohn's disease: 1998-2000. Aliment Pharmacol Ther (2011) 1.37
Prefrontal cortical hypometabolism during low-dose interferon alpha treatment. Psychopharmacology (Berl) (2000) 1.35
Development of a valid and reliable malnutrition screening tool for adult acute hospital patients. Nutrition (1999) 1.34
Growth and relaxation processes in Ge nanocrystals on free-standing Si(001) nanopillars. Nanotechnology (2012) 1.32
The scored Patient-generated Subjective Global Assessment (PG-SGA) and its association with quality of life in ambulatory patients receiving radiotherapy. Eur J Clin Nutr (2003) 1.31
Medical decompression of toxic megacolon by "rolling". A new technique of decompression with favorable long-term follow-up. J Clin Gastroenterol (1988) 1.30
The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. Brain (2001) 1.29
Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest (1992) 1.28
Induction of an interleukin-1 receptor (IL-1R) on monocytic cells. Evidence that the receptor is not encoded by a T cell-type IL-1R mRNA. J Biol Chem (1990) 1.26
Serotonergic genes modulate amygdala activity in major depression. Genes Brain Behav (2006) 1.25
Language mapping in less than 15 minutes: real-time functional MRI during routine clinical investigation. Neuroimage (2001) 1.24
A dynamic relationship between myopia and blur-driven accommodation in school-aged children. Vision Res (1995) 1.24
Lipopolysaccharide-free conditions in primary astrocyte cultures allow growth and isolation of microglial cells. J Neurosci (1989) 1.22
Interleukin-6 and selected plasma proteins in healthy persons of different ages. Neurobiol Aging (1995) 1.20
Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis. Br J Cancer (2012) 1.19
Hippocampal apoptosis in major depression is a minor event and absent from subareas at risk for glucocorticoid overexposure. Am J Pathol (2001) 1.19
Identification and differential expression of a novel alternative splice isoform of the beta A4 amyloid precursor protein (APP) mRNA in leukocytes and brain microglial cells. J Biol Chem (1992) 1.18
Transgenic mice with cardiac-specific expression of activating transcription factor 3, a stress-inducible gene, have conduction abnormalities and contractile dysfunction. Am J Pathol (2001) 1.17
Establishment and characterization of the follicular thyroid carcinoma cell line ML-1. J Mol Med (Berl) (2000) 1.15
Nicotine and cotinine stimulate secretion of basic fibroblast growth factor and affect expression of matrix metalloproteinases in cultured human smooth muscle cells. J Vasc Surg (1996) 1.14
Expression and regulation of cyclooxygenase-2 in rat microglia. Eur J Biochem (1997) 1.14
Protein translocon at the Arabidopsis outer chloroplast membrane. Biochem Cell Biol (2001) 1.12
Functional (conversion) neurological symptoms: research since the millennium. J Neurol Neurosurg Psychiatry (2012) 1.11
Endotoxin-induced appearance of immunoreactive interleukin-1 beta in ramified microglia in rat brain: a light and electron microscopic study. Neuroscience (1995) 1.10
Rare BRAF mutations in melanoma patients: implications for molecular testing in clinical practice. Br J Cancer (2013) 1.10
Epileptic but not psychogenic seizures are accompanied by simultaneous elevation of serum pituitary hormones and cortisol levels. Neuroendocrinology (1989) 1.10
Neuropeptide S receptor gene -- converging evidence for a role in panic disorder. Mol Psychiatry (2010) 1.09
Reactive oxygen species are involved in the pathogenesis of experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol (1995) 1.09
Poor nutritional status prior to peripheral blood stem cell transplantation is associated with increased length of hospital stay. Bone Marrow Transplant (2005) 1.08
Search for supersymmetry at the LHC in events with jets and missing transverse energy. Phys Rev Lett (2011) 1.08
The effects of weightlessness on the human organism and mammalian cells. Curr Mol Med (2011) 1.08
Characteristics of moving visual scenes influencing spatial orientation. Vision Res (1975) 1.07
Regional cerebral blood flow during focal seizures of temporal and frontocentral onset. Ann Neurol (1990) 1.07
Search for stopped Gluinos in pp collisions at square root s=7 TeV. Phys Rev Lett (2011) 1.07
Axial p-n junctions realized in silicon nanowires by ion implantation. Nano Lett (2009) 1.07
Characterization of lactobacilli towards their use as probiotic adjuncts in poultry. J Appl Microbiol (2002) 1.06
Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors. Glia (1996) 1.05
Spatial vision in Alzheimer's disease. General findings and a case report. Arch Neurol (1985) 1.03
Malnutrition among gynaecological cancer patients. Eur J Clin Nutr (2006) 1.03
Splenic cyst--definitive treatment by laparoscopy. Gastrointest Endosc (1985) 1.03
A randomised control trial comparing lifestyle groups, individual counselling and written information in the management of weight and health outcomes over 12 months. Int J Obes (Lond) (2006) 1.02
Validation of a malnutrition screening tool for patients receiving radiotherapy. Australas Radiol (1999) 1.01
Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain (2001) 1.00
Doubling of the tuberculosis incidence in Greenland over an 8-year period (1990-1997). Int J Tuberc Lung Dis (2001) 1.00
Phase II trial of intralesional therapy with interleukin-2 in soft-tissue melanoma metastases. Br J Cancer (2003) 1.00
Worksite health promotion in Colorado. Public Health Rep (1985) 1.00
Adenosine A2b receptors mediate an increase in interleukin (IL)-6 mRNA and IL-6 protein synthesis in human astroglioma cells. J Neurochem (1996) 1.00
Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: two case reports. Clin Infect Dis (1998) 1.00
Disseminated infection with Mycobacterium genavense: a challenge to physicians and mycobacteriologists. J Clin Microbiol (1999) 0.99
Treatment of ocular melanoma metastatic to the liver by hepatic arterial chemotherapy. J Clin Oncol (1997) 0.99
Measurement of the polarization of W bosons with large transverse momenta in W + jets events at the LHC. Phys Rev Lett (2011) 0.99
An international dermatological image atlas on the WWW: practical use for undergraduate and continuing medical education, patient education and epidemiological research. Stud Health Technol Inform (1998) 0.99
The low density lipoprotein receptor gene family. Differential expression of two alpha2-macroglobulin receptors in the brain. J Biol Chem (1998) 0.99
A reliable fluorescent stain for fungi in tissue sections and clinical specimens. Mycopathologia (1984) 0.99
Measurement of the inclusive jet cross section in pp collisions at √s = 7 TeV. Phys Rev Lett (2011) 0.98
The role of SiGe buffer in growth and relaxation of Ge on free-standing Si(001) nano-pillars. Nanotechnology (2012) 0.98
Search for neutral minimal supersymmetric standard model Higgs bosons decaying to tau pairs in pp collisions at √s=7 TeV. Phys Rev Lett (2011) 0.97
Hypoplastic left heart syndrome: "Which is the best operative strategy?". Ann Thorac Cardiovasc Surg (1998) 0.97